INFLUENZA VIRUS INFECTIONS IN TRANSPLANT RECIPIENTS: A MULTICENTER REGISTRY

Withdrawn

• Conditions: Influenza infection; virus infections; 10047438

• Registration Number: NL-OMON35721
• Lead Sponsor: niversity of Alberta

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Liver transplanta patients on at least one immunosuppressive medication

Exclusion Criteria

Unable to provide informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary study endpoint is value of the Quantitative influenza PCR assay<br /><br>from NP swabs at the 6 measuring points as a measure for viral shedding after<br /><br>infection.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints include<br /><br>- immune response to Influenza at 4 and 6 weeks after infections<br /><br>- viral resistance testing at first and last positive swab<br /><br>- Subtyping of influenza virus</p><br>